Abstract: The disclosure relates to a process for producing ammonia. A hydrocarbon mixture and steam are supplied to a primary reformer. The hydrocarbon mixture and the steam are at least partly converted to carbon monoxide and hydrogen in the primary reformer. The gas mixture from the primary reformer is directed into a secondary reformer. The secondary reformer is supplied with process air, at least comprising oxygen and nitrogen, such that unconverted hydrocarbon is converted to carbon monoxide and hydrogen.

Abstract: A cooling device including a first storage compartment and a second storage compartment disposed adjacent to the first storage compartment. An evaporator is disposed adjacent a wall of the second storage compartment. An air distributor assembly is disposed within the second storage compartment such that the evaporator is positioned between the air distributor assembly and the wall. The air distributor assembly includes an air plenum and a first flow path defined therein. A first damper is disposed within the air distributor assembly. The first damper is movable between first and second positions. When the first damper is in the first position, a first portion of airflow received in the air plenum is permitted to flow into the first flow path. When the first damper is in the second position, the first portion of the airflow is hindered from flowing into the first flow path.

Abstract: The present disclosure is directed to multi-functional isolation pads that can be used in combination with both clamp-on cable trays and guide-on cable trays without any user manipulation (e.g., folding) of the isolation pad.

Abstract: The present disclosure is directed to multi-functional isolation pads that can be used in combination with both clamp-on cable trays and guide-on cable trays without any user manipulation (e.g., folding) of the isolation pad.

Abstract: Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments.

Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment, and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.

Abstract: A work vehicle may include an internal combustion engine, aftertreatment system, and at least one controller. The controller is configured to use a temperature of the aftertreatment system to determine a hydrocarbon level of the aftertreatment system, and set an idle speed of the engine to high idle if the hydrocarbon level is above a hydrocarbon ceiling, to ultra-low idle if the hydrocarbon level is below a hydrocarbon floor, and to low idle if the hydrocarbon level is between the hydrocarbon floor and the hydrocarbon ceiling.

Abstract: A work vehicle may include an internal combustion engine, aftertreatment system, and at least one controller. The controller is configured to use a temperature of the aftertreatment system to determine a hydrocarbon level of the aftertreatment system, and set an idle speed of the engine to high idle if the hydrocarbon level is above a hydrocarbon ceiling, to ultra-low idle if the hydrocarbon level is below a hydrocarbon floor, and to low idle if the hydrocarbon level is between the hydrocarbon floor and the hydrocarbon ceiling.

Abstract: The present disclosure is directed to multi-functional isolation pads that can be used in combination with both clamp-on cable trays and guide-on cable trays without any user manipulation (e.g., folding) of the isolation pad.

Abstract: Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments.

Abstract: Anti-A? globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies. The present invention relates to anti-A? globulomer antibodies having a binding affinity to A?(20-42) globulomer that is greater than the binding affinity of the antibody to A?(1-42) globulomer, antigen-binding moieties thereof, hybridomas producing said antibodies, nucleic acids encoding said antibodies, vectors comprising said nucleic acids, host cells comprising said vectors, methods of producing said antibodies, compositions comprising said antibodies, therapeutic and diagnostic uses of said antibodies and corresponding methods relating to Alzheimer's disease and other amyloidoses.

Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.

Abstract: The present invention relates to a method for the determination of a concentration (C) of a polyacrylic acid (PAA) in an aqueous medium (AM) wherein the determination is performed photometrically in the presence of a dye (I). The present invention furthermore, relates to a method for the determination of a concentration (C) of a polyacrylic acid (PAA) in an aqueous medium (AM) wherein at least two different transmittance values are measured using at least two different wavelengths and wherein the at least two different transmittance values are analyzed to determine the concentration (C) of the polyacrylic acid (PAA). The present invention also relates to the use of a dye (I) for the determination of the concentration (C) of a polyacrylic acid (PAA).

Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.

Abstract: The present invention relates to a container for cored wires, in particular cored wires that are filled with a hazardous material and/or a filling that is sensitive to air, oxygen, water and/or moisture, for safely transporting and for safely storing said cored wires.

Abstract: The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.

Abstract: The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.

Abstract: Systems and methods for remanufacturing solenoid valves that enable the repair, reassembly, and reuse of a solenoid are disclosed which may allow for a solenoid valve to be restored to proper working condition and avoid the need to completely replace a malfunctioning solenoid valve. Embodiments may also include solenoid remanufacturing kits that may include a brace for securing a valve housing of a remanufactured solenoid that has been opened for repair.

Abstract: Valve assemblies and associated methods are disclosed that may include a spool valve and one or more stationary inserts. In some examples, the stationary inserts may be configured to be fixed within a valve bore of a valve body to provide a fluid seal between an outer surface of the insert and the valve bore. Embodiments may also include valve assembly repair kits that may include a spool valve and a stationary insert for repairing a malfunctioning spool valve and methods for installing the same.